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Bovine mastitis is one of the most common diseases among dairy cows and causes
high economic losses in dairy industries worldwide. Streptococcus uberis is one of the
most frequently identified pathogens causing the disease. In this study, 153 S. uberis
strains isolated from mastitis milk samples were analyzed for their genetic diversity
using multi locus sequence typing (MLST). Moreover, antibiotic susceptibility testing was
performed using a microdilution assay and 11 antimicrobial agents including penicillin,
which is the first line agent for treatment of bovine mastitis in Switzerland. MLST was
successful for 152 (99.3%) of the strains. Overall, 103 different sequence types (STs)
were determined, including 91 novel STs. S. uberis belonging to clonal complex (CC)
5 represented 47 (30.7%) of the mastitis cases. Two (1.3%) of the strains belonged
to CC86 and one (0.7%) to CC143. The population structure identified in this work
suggests that environmental transmission is the predominant route of infection in herds
in Switzerland. Antimicrobial susceptibility testing determined a resistance rate of 11.8%
for pirlimycin and elevated MIC90-values for marbofloxacin as well as for erythromycin.
This study highlights the importance of genetic characterization of S. uberis and the need
for veterinary breakpoints for surveillance of antimicrobial resistance in S. uberis.
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INTRODUCTION
Bovine mastitis is considered to be one of the most common diseases causing high economic losses
in dairy industries worldwide (1). The economic losses include not only costs for treatment but
deficits due to decreased quantity and quality of milk, higher number of culling and death of
affected animals (2). Several studies reported Streptococcus uberis as one of the most frequently
identified pathogens causing clinical cases of bovine mastitis (3–5). S. uberis is adapted to cattle
and is classified as an environmental pathogen detected on various sites not only on the host but
in bedding material, on milking utensils and other objects in the surroundings of cattle housing
(6). Following the implementation of preventive control measures, the prevalence of clinical
mastitis has declined in many countries during the last decades (7). Enhanced milking hygiene
(correctly maintained equipment, teat disinfection, and personnel hygiene), antibiotic treatment
and culling of persistently infected animals reduced the microbial load with contagious pathogens
and therefore the risk for new infections. Nevertheless, the control of environmental pathogens
like S. uberis presents an ongoing challenge for the management of dairy herds (8, 9). Despite the
evidence supporting the essential role of S. uberis in the prevalence of bovinemastitis, only a limited
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amount of research has been carried out with regard to the
characterization of S. uberis strains in Central Europe.
Streptococcus spp. are known to show good susceptibility to
penicillin (9, 10) which is recommended by the Swiss society
for veterinary science (SSV) as first line antimicrobial agent for
intramammary treatment in cases of bovine mastitis caused by
Streptococcus spp. and Staphylococcus spp. including S. aureus
(11). The increasing numbers of resistant strains observed in
association with the extensive use of antibiotics in human and
veterinary medicine worldwide has led to the development
of various monitoring programs in different countries. The
possibility of resistant bacteria entering the food chain and the
implicated risk to human health are only some of the reasons
to enhance resistance surveillance. In the last two decades a
growing number of publications have documented a slow but
obvious decrease in beta-lactam susceptibility in streptococci
(10). Even though most of the isolates examined in these studies
were still considered susceptible to beta-lactam-antibiotics, this
development underlines the need for further surveillance of
antimicrobial resistance in order to ensure secure antibiotic
treatment for future generations.
The aim of this study was to analyze the genetic diversity
and the antimicrobial susceptibility profiles of S. uberis strains
isolated from mastitis milk samples collected during a 1-year
period from cattle on dairy farms in the area of the canton of
Zürich, Switzerland.
MATERIALS AND METHODS
Bacterial Isolation and Species
Identification
The dairy farms selected for this study were customers of the
ambulatory veterinary hospital of the University of Zürich that
services the canton of Zürich and the surrounding region. The
average herd size in the study region is 20–30 cows, and the
most common dairy cow is the Swiss Brown. Clinical mastitis
diagnosis was performed by the veterinarian in charge according
to a standardized procedure. Milk samples were submitted to the
routine mastitis diagnostic laboratory of the Institute for Food
Safety and Hygiene in Zürich.
Milk samples were cultured according to standard procedures
(12). Strains were identified using the Christie–Atkins–Munch-
Petersen (CAMP) test as described byMunch-Petersen et al. (13),
followed by an esculin hydrolysis (ESC) test. Briefly, a single
colony was inoculated into an esculin broth medium (BioRad,
Cressier, Switzerland) and incubated at 37◦C for 24 h. After
incubation, fluorescence was examined using an ultraviolet light
source. Loss of fluorescence was interpreted as an ESC positive
result. A Streptococcus agalactiae strain was used as an ESC
negative control.
Species identification was confirmed by matrix-assisted laser
desorption/ionization time of flight (MALDI-TOF) spectrometry
(Bruker BioSpin AG, Fällanden, Switzerland) according to
manufacturer’s instructions. All S. uberis strains were cultured on
sheep blood agar plates (24 h at 37◦C), transferred into a glycerol
freezing media and stored at−80◦C until further processing.
Over a 1-year period (January 2017–January 2018), a total
of 153 S. uberis strains were collected. Table S1 provides an
overview of the strains used in this study.
DNA Extraction
DNA isolation was performed after 24 h incubation in Brain-
Heart-Infusion (BHI) medium at 37◦C using the GenElute
Bacterial DNA Kit supplied by SIGMA-ALDRICH (Darmstadt,
Germany) following the manufacturer’s instructions. A
Nanodrop ND-1000 UV/Vis spectrophotometer (NanoDrop
Technologies, Wilmington, DE) was used to determine the
concentration of nucleic acids in the extractions.
Multi Locus Sequence Typing (MLST)
MLST was performed using the GoTaq PCR system (Promega
AG, Dübendorf, Switzerland) as well as primers and cycling
conditions previously described by Coffey et al. (14). Briefly,
target regions of arcC, ddl, gki, recP, tdk, tpi, and yqiL were
amplified, PCR product purification as well as subsequent
sequencing were outsourced (Microsynth, Balgach, Switzerland).
Due to poor sequencing results a new forward primer was created
for one of the seven housekeeping genes: yqiL fw new (5
′
-GGA
TAC TCA TCT TGT GAG ACG ATT AAA GG-3
′
). Reverse
primer and cycling conditions remained unchanged. Sequence
data analysis was performed using CLC Main Workbench 8.0.1.
The allelic profile of each strain was identified and, where
possible, strains were assigned to sequence types (ST) using the
PubMLST sequence and profile definitions database (https://
pubmlst.org). Currently unidentified alleles of each housekeeping
gene as well as unknown allelic profiles were submitted to the
database and new sequence types (ST) were generated. Data
was visualized using the platform independent JAVA software
phyloviz 2.0 and the goeBURST algorithm (15).
Antimicrobial Susceptibility Testing
Minimum inhibitory concentrations (MIC) of various
antimicrobial agents were determined by the microdilution
assay using the MICRONAUT-S Mastitis 3 system
(MERLIN, Bornheim-Hersel, Germany) according to
manufacturer’s instructions. The test system included
the following antimicrobial agents: penicillin, ampicillin,
cefazolin, cefoperazone, cefquinome, oxacillin, pirlimycin,
erythromycin, marbofloxacin, amoxicillin/clavulanic acid,
and kanamycin/cephalexin,
The MIC50 and MIC90 values (MICs at which at least 50 and
90% of the isolates in a test population are inhibited, respectively)
were determined.
RESULTS
In total, 153 S. uberis strains were isolated from milk samples
originating from 54 herds, with the majority (87%) of the farms
located in the canton of Zurich. Twenty-six (48%) of the 54 herds
were sampled more than once with every sample deriving from
a new case of mastitis diagnosed by the veterinarian in charge.
Acute mastitis was diagnosed in 68 cases, subclinical in 17, and
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chronic mastitis in 14 cases, respectively. For 54 cases, the type of
mastitis was unspecified (Table S1).
MLST identified 96 different alleles among the seven gene
fragments, whereof 21 were found for the first time in this study.
Between one and six new alleles per housekeeping gene were
detected among the 153 S. uberis isolates. The highest number of
new alleles was detected for tdkwith six new alleles, and ydiLwith
five new alleles, respectively (Table S1). The nucleotide sequences
of the novel alleles are registered in the S. uberisMLST sequence
and profile definitions database (https://pubmlst.org) and can be
accessed for each locus using the allele IDs listed in Table S1.
Based on the allelic profiles, 152 strains were assigned to 103
different STs, whereof 91 (88.3%) were newly described STs. One
isolate (SU162) did not generate an amplification product for the
locus yqiL and was therefore not assigned an ST.
The most frequently detected ST was ST896 (n = 10). This
ST was novel and belonged to clonal complex (CC)5, together
with further 22 novel STs (n= 29) and previously described ST6,
ST22, ST316, ST241, and ST361 (n = 8). In total, CC5 contained
47 strains from 30 farms (Table S1).
The goeBURST analysis indicated three possible founder STs
within CC5 (ST6, ST241, and ST361). ST6 contained one isolate
and had one isolate that was a single locus variant (SLV) and five
strains that were double locus variants (DLVs). ST241 consisted
of one isolate and had one isolate that was an SLV and 15 strains
that represented DLVs. ST361 (one strain) had six strains that
were SLVs strains and one strain representing a DLV (Figure 1).
Of the 47 strains belonging to CC5, 22 (46.8%) were associated
with acute mastitis, 7 (14.9%) with subclinical, and 3 (6.4%) with
chronic mastitis. For the remaining 15 (31.9%) of the strains, the
type of mastitis was unspecified (Figure 1 and Table S1).
Further clonal complexes included CC86 (n = 2), and
CC143 (n = 1), whereof both ST891 and ST962 (CC86) were
novel (Table S1).
The remaining 73 STs (n= 102) did not belong to any CC and
consisted of 67 novel STs (n = 94) and six previously described
STs (n = 8). Thereof, 45 (44.1%) were associated with acute
mastitis, 9 (8.8%) with subclinical, and 10 (9.8%) with chronic
mastitis. For 38 (37.3%), the type of mastitis was unspecified
(Figure 1 and Table S1).
Figure 2 shows the relationship between the STs of this study
and those reported globally in the S. uberis MLST database
(pubmlst.org/suberis).
Antimicrobial susceptibility testing was performed for all 153
S. uberis strains investigated in this study. A summary of the
MICs and the MIC50/MIC90 values is presented in Figure 3. Of
the antimicrobial agents tested, pirlimycin is the only one with
a defined breakpoint (≥4µg/ml) for Streptococcus spp. isolated
from cattle mastitis (16). Thereby, 18 (11.8%) strains originating
from nine different farms (farms F8, F15, F16, F22, F30, F31,
F35, F36, and F51, respectively) were resistant to pirlimycin
while MICs remained ≤1µg/ml for the remaining 135 (88.2%)
of the isolates, which was the lowest measurable concentration
for this agent in the MICRONAUT assay (Table S1). A total
of 24 strains (15.7%) from 13 farms were able to grow at all
tested dilutions of erythromycin in the assay, setting the MIC90
at >4µg/ml (Figure 3). Seventeen of these strains were among
those resistant to pirlimycin, as mentioned above. The remaining
seven originated from farms F1, F4, F13, F25, F31, and F43,
respectively (Table S1).
For seven (4.6%) of the strains the MICs of marbofloxacin
were 2-fold higher (≥2µg/ml) than the MIC50 andMIC90 (both
1µg/ml, respectively). For two (1.3%) of the isolates, the MICs
of penicillin were slightly increased (0.25µg/ml), but remained
≤0.125µg/ml for the remaining 151 strains.
All 153 isolates tested in this study showed a good
susceptibility to ampicillin, cefazolin, cefoperazone, cefquinom,
oxacillin, and kanamycin-cephalexin, with MICs of 4, 4, 2, 1, 1,
and 4/0.4µg/ml, respectively (Figure 3). All values represent
the lowest measurable concentrations in the MICRONAUT
assay. All isolates also exhibited good susceptibility to
amoxicillin/clavulanic acid, with MICs of 4/2 µg/ml).
DISCUSSION
In this study, we assessed the genetic relatedness and the
antimicrobial resistance of S. uberis causing bovine mastitis
on 54 farms in Switzerland during 2017. The main limitation
of this study was the restriction to one geographical area in
Switzerland. However, farm type, breed of dairy cows and
herd size were typical for the Swiss Midlands. The analysis
performed revealed that the 153 isolates belonged to 103 STs,
with 30.7% of the isolates assigned to CC5. This CC has been
identified as the major lineage among S. uberis isolates causing
bovine mastitis in the UK (14, 17). Our data confirm the
wide distribution of this lineage. Other previously described
S. uberis CC86 and CC143 were detected at very low rates
of 1.3 and 0.7%, respectively, supporting earlier reports that
these clones are rare in Europe compared to Australia and
India (14, 17–20).
Within CC5 we identified a high number of STs, including
STs described for the first time in this study. The high diversity
of STs both within CC5 as also among the other STs, suggests
a heterogeneous, rather than a contagious dissemination of
S. uberis among the dairy cattle from the farms analyzed in
this study, e.g., through environmental contamination. The
goeBURST analysis showed that the Swiss strains from 2017 were
distributed among CC5, CC86, CC143 in the global population
of S. uberis (Figure 2). There were some inconsistencies where
one isolate belonging to ST932, which is an SLV of ST184
(CC143), and ST943, which is a DLV of ST124 (CC143), were not
assigned to this CC by the MLST database (Figure 2). Likewise,
ST911, an SLV of ST22 (CC86) was not assigned to CC86. These
observations indicate that these CCs may be more prevalent than
suggested by the database.
The comparison of the STs from this study with those
of 38 S. uberis strains submitted to the isolate database at
pubmlst.org/suberis from Switzerland during 2008 shows only
one common ST (ST319) (Figure 2). This is a further indication
that the majority of S. uberis from Swiss dairy cattle represent
unique genomic backgrounds and lack predominant contagious
STs such as ST5, ST6, ST20, and other STs of the CC5 compared
to other European countries such as the UK (17).
Frontiers in Veterinary Science | www.frontiersin.org 3 July 2019 | Volume 6 | Article 234
Käppeli et al. Sequence Types of S. uberis
FIGURE 1 | Multilocus sequence type (MLST)-based minimal spanning tree of 152 Streptococcus uberis isolated from bovine mastitis milk during 2017 in
Switzerland. The tree was calculated and generated using the goeBURST full MST algorithm in Phyloviz 2.0. Node sizes reflect the number of isolates with specific
MLST profile. Numbers within the nodes indicate the ST. Node colors refer to types of mastitis: acute (red), subclinical (green), chronic (orange), unspecified mastitis
(blue). Numbers on lines indicate locus variants between adjacent nodes. Grey shadows indicate STs belonging to clonal complex (CC)5.
Nevertheless, of the 54 herds examined, 13 (24%) had two or
more individual cows infected with S. uberis that belonged to
identical STs. For one herd (farm 14), five cases of acute mastitis
were associated with ST933 (CC5), suggesting contagious events.
Furthermore, for three herds, four cases each of either acute
mastitis or unspecified mastitis associated with ST896 (CC5) on
farm 16, ST963 on farm 31, and ST971 on farm 14 were observed.
While these data suggest potential transmission events, this study
is limited by the lack of detailed recordings of the clinical
cases within the affected herds. More precise documentation
on the temporal patterns of the occurrence of specific STs is
needed in order to identify potentially contagious transmission
episodes. Moreover, further molecular mechanisms that may
promote the higher prevalence of specific STs such as virulence
factors, were not analyzed in this study. Additional investigations
are required to characterize such factors in various S. uberis
STs, including factors affecting biofilm formation (21), host cell
invasion, survival in the host environment or evasion of host
immune response, respectively (18, 22, 23).
In the present study, we determined MICs of 11 antimicrobial
agents, including penicillin, which is the first line antimicrobial
according to the prescription policy of the ambulatory veterinary
hospital of the University of Zürich, and amoxicillin/clavulanic
acid which is the second-line drug of choice for the treatment of
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FIGURE 2 | MLST-based minimal spanning tree of all S. uberis isolates in the S. uberis MLST database (pubmlst.org/suberis). Node colors refer to origin of isolates:
this study (red), Switzerland during 2008 (green), UK (blue), other countries (dark gray). Node sizes reflect the number of isolates with specific ST. Clonal complexes
are indicated in bold. STs from this study that are discussed in the main text are indicated with arrows.
FIGURE 3 | Minimal inhibitory concentrations (MICs) of 11 antimicrobial agents for 153 Streptococcus uberis isolated from bovine mastitis milk during 2017 in
Switzerland. Numbers indicate the number of strains exhibiting the corresponding MIC value. Light blue areas represent the tested concentration range on the
microdilution plate. Values above this range denote MIC values greater than the highest concentration tested. The breakpoint (≥4µg/ml) for pirlimycin is indicated by a
blue vertical bar. MIC50 and MIC90 values represent the concentrations of antimicrobial agents inhibiting growth of 50 or 90% of the strains, respectively.
S. uberis mastitis. Erythromycin was tested as a representative of
macrolides, which are third-line antimicrobials recommended by
the SGV for the treatment of S. uberis infections (11). The other
agents were tested for epidemiological purposes.
Due to the lack of interpretive criteria for mastitis strains,
an accurate classification into susceptible or resistant strains,
as well as the specification of a resistance rate was possible
for the lincosamide pirlimycin only. Pirlimycin resistance was
limited to nine farms and within these farms, five had two or
more individual cows infected with resistant isolates. Notably,
on farm eight and farm 31, resistant isolates were associated
with ST963, which is potentially a contagious ST, as mentioned
above. The majority of the pirlimycin resistant isolates in
this study also exhibited erythromycin MICs of >4µg/ml. S.
uberis with this resistance phenotype harboring ermB have been
described from bovine mastitis cases in France (24). Additional
studies are needed to determine the resistance genotype of the
isolates described in this study. Furthermore, monitoring the
development of resistance in S. uberis is required.
In the absence of veterinary clinical breakpoints, a potential
alternative to monitor the development of antimicrobial
susceptibility of animal pathogens like S. uberis is to track
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an increase or decrease of MIC50/MIC90 values over time.
Reports providing such data for Switzerland are scarce. A study
analyzing 208 S. uberis isolates in 2013 recorded MIC50/MIC90
values for penicillin of ≤0.12 µg/ml/ ≤ 0.12µg/ml, similar
to our data (25). However, a direct comparison is not feasible
due to differences in laboratory methods. Only one recently
published study presenting the results of an ongoing long-term
susceptibility monitoring program in European countries
(VETPATH) includes MIC50/MIC90 values (26). Compared
to our study, the S. uberis strain collection examined in the
VETPATH program expressed higher MIC90 values for penicillin
and marbofloxacin with 0.25 and 2µg/ml, respectively, while
the values for the combination of kanamycin-cephalexin
were identical with those determined in our study. Due to a
strong variance in the dilution range tested, the differences
in the MIC50/MIC90-values for amoxicillin-clavulanic acid,
cefquinome and erythromycin could not be compared between
the two studies.
Ignoring potential interspecies differences in
pharmacokinetics as well as the fact that S. uberis is a cattle-
adapted species, we attempted to determine and compare
resistance rates using breakpoints published for human viridans
streptococci (16), as described previously for the pan-European
monitoring program VETPATH (21). There, resistance rates of
0.0% and 20.2% for penicillin and erythromycin, respectively,
were calculated for S. uberis. Using the same breakpoints
(≥4µg/ml for penicillin and ≥1µg/ml for erythromycin),
similar resistance rates of 0.0% for penicillin and 15.7% for
erythromycin, respectively, were observed for our strain
collection. Furthermore, we observed a resistance rate of 0.0%
for ampicillin (breakpoint ≥ 8µg/ml), an agent that was not
included in the VETPATH study. In contrast, the collected
data from the French surveillance program (RESAPATH),
was interpreted using different breakpoints published by
the veterinary section of the Comité de l’antibiogramme
de la Société Française de Microbiologie (CA-SFM) for
Streptococci spp. (27, 28). Unsurprisingly, the French study
presented resistance rates for S. uberis similar to those of the
pan-European study with 0.0% for penicillin and 20.0% for
erythromycin. Moreover, using the CA-SFM breakpoint for
ampicillin (16µg/ml) classified the resistance rate of resistance
at 0.0%, accordingly.
With the aim of providing interpretive criteria and of
harmonizing diagnostic procedures for mastitis isolates, Fessler
et al. (29), determined the MICs as well as disc diffusion
diameters of a total of 1,086 bovine clinical isolates challenged
with cefoperazone. Considering pharmaceutical studies and
treatment recommendations, they proposed to classify the
different species tested, including S. uberis, as susceptible
to cefoperazone when the MIC is ≤2µg/ml, intermediate
when the MIC is 4µg/ml and resistant when the MIC is
≥8µg/ml. Utilizing these breakpoints for interpretation of our
data, we considered 100% of our isolates as fully susceptible
to cefoperazone.
Our study underlines the need for veterinary clinical
breakpoints in order to improve surveillance data
and optimize treatment of bovine mastitis and other
animal diseases.
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